DEUTSCHE AKADEMIE DER WISSENSCHAFTEN UND KÜNSTE
SCIENTIFICALLY INTRODUCING UNIVERSALITY TO THE UNIVERSITY
peter huebner • micro music laboratories
M E D I C A L   R E S O N A N C E   T H E R A P Y   M U S I C®
R E D U C T I O N   O F   P S Y C H O – P H Y S I O L O G I C A L   M A N I F E S T A T I O N S   O F   S T R E S S

Home

Site Map

Motto

The Cosmic
Education Program

Introduction

Peter Hübner
Developer of the University

 

Faculty of
MEDICAL SCIENCES

Leading Thoughts

Logical Path - Theory

Logical Path - Practice

CURRICULUM

Theoretical Fundamentals

Medical Music
Preparations on CD

Scientific Research

Research Fields in Detail

Cerebral &
Nervous System

Cerebral Arteries

Brain Asymmetry

Reduction of Beta Waves

Neurotransmission Speed

Epileptic Attacks

Epileptic Attacks

Degree of Amnesia

Epilepsy Treatment

Epileptic Attacks

Brain Asymmetry

Haemodynamic

 

 

Astronomy of Mind EQ x IQ

Hall of Harmony

International Experts

Educational Program
Health

Scientific Research

International Media

International Congresses

Membership

Application to the University

 

 






Reduction of Beta-Waves in Patients with
Multiple Sclerosis
The therapy program was composed of 4 thera­peu­tic blocks of 6 days each. In these 6 days the patients were treated with 19 dif­fer­ent compositions of Medical Resonance Ther­apy Music® in a specific sequence.

Three treatments per day were given in­di­vidu­ally in the room (morning, noon, and evening) and two treatments per day in the group (be­fore lunch and afternoon) Therapy time per day was 4-5 hours. The whole program of 4 blocks was taken by 3 MS-patients (Mr A, 41 years old, development of MS in attacks with partly remissions; Mrs B, 52 years old, slow chronically progressing form of MS; Mrs C, 36 years old, development of MS in attacks with partly remissions).

As clinical parameter EEG observations were recorded before starting with the treatment, after 2 and after 4 therapy blocks. These re­cordings documented a reduction of beta waves.



Mr A


before starting with MRT-Music® treatment

EEG of basic alpha type, without indication of focus or spasm potentials

after 2 therapy blocks

EEG of basic alpha type, without indication of focus or spasm potentials, less beta waves

after 4 therapy blocks

EEG of basic alpha type, without indication of focus or spasm potentials, less beta waves










The results in detail:



Mrs B


before starting with MRT-Music® treatment

EEG with mixed alpha-beta waves, strongly covered by muscular artifacts, without in­di­ca­tion of focus or spasm potentials

after 2 therapy blocks

EEG with mixed alpha-beta waves, strongly covered by muscular and tremor artifacts, without indication of focus or spasm po­ten­tials, less beta waves

after 4 therapy blocks

EEG of alpha type, strongly covered by mus­cu­lar and tremor artifacts, in comparison to measurement 2 a more speedy alpha rhythm



Mrs C


before starting with MRT-Music® treatment

EEG: rich with beta waves, of basic alpha type, without indication of focus or spasm po­ten­tials

after 2 therapy blocks

EEG: rich with beta waves, of basic alpha type, without indication of focus or spasm po­ten­tials, less beta waves

after 4 therapy blocks

EEG: rich with beta waves, of basic alpha type, without indication of focus or spasm po­ten­tials, less beta waves





Comment

The overall effect of the treatment with MRT-Music® was judged by Dr. med. Mihr as well as by the patients so positive that Dr. med. Mihr became active to put the research at his hospital under the guidance of one of the most renowned EEG specialists in Germany, Prof. Gallhofer from the University of Giessen, who was also very interested to do this. But then, through the change of various organizational circumstances, it was not possible any more to accomplish this.

But Dr. med. Mihr presumes that a very diverse and detailed EEG observation of patients under treatment with MRT-Music® with modern and sophisticated EEG technology would bring out many interesting features of MRT-Music® helpful for the treatment of multiple sclerosis. Interested re­search­ers are cordially invited to follow this up.



 

Investigator:

Dr. med. Mihr